We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Psoralen plus UVA protocol for Compositae photosensitivity.
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society 1996 September
BACKGROUND: Patients allergic to sesquiterpene lactones found in Compositae plants may develop severe photosensitivity, which can result in persistent light reaction. Treatment of these exquisitely photosensitive individuals can be very difficult, often requiring hospitalization. Although some treatment regimens have used psoralen plus UVA (PUVA) therapy, no specific outpatient protocol has been established
OBJECTIVE: The purpose of this study was to develop an effective PUVA outpatient regimen to treat compositae photosensitivity.
METHODS: A prednisone-assisted PUVA protocol was established in which the prednisone does was decreased weekly, and the PUVA dose was increased during the same time interval.
RESULTS: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions.
CONCLUSIONS: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.
OBJECTIVE: The purpose of this study was to develop an effective PUVA outpatient regimen to treat compositae photosensitivity.
METHODS: A prednisone-assisted PUVA protocol was established in which the prednisone does was decreased weekly, and the PUVA dose was increased during the same time interval.
RESULTS: Both patients enrolled in the study experienced dramatic improvement in their previously unresponsive eruptions.
CONCLUSIONS: Two men aged 66 and 80 years were subjected to this protocol. Both men had chronic photodistributed dermatitis that resolved with this treatment and in one instance has remained clear for 18 months without needing further PUVA therapy.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app